Publisher
Springer Science and Business Media LLC
Reference84 articles.
1. Morris, S. W. et al. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin’s lymphoma. Science-New York Then Washington-, 1281–1281 (1994).
2. Shiota, M. et al. Hyperphosphorylation of a novel 80 kDa protein-tyrosine kinase similar to Ltk in a human Ki-1 lymphoma cell line, AMS3. Oncogene 9, 1567–1574 (1994).
3. Soda, M. et al. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature 448, 561–566 (2007).
4. Kruczynski, A., Delsol, G., Laurent, C., Brousset, P. & Lamant, L. Anaplastic lymphoma kinase as a therapeutic target. Expert opinion on therapeutic targets 16, 1127–1138 (2012).
5. Mossé, Y. P., Wood, A. & Maris, J. M. Inhibition of ALK signaling for cancer therapy. Clinical Cancer Research 15, 5609–5614 (2009).
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献